SAVE KRATOM

The National Institute on Drug Abuse has awarded researchers at the University of Florida College of Pharmacy a two-year, $3.5 million grant to bolster research on Mitragyna speciosa, or kratom, and its potential to treat opioid misuse and physical dependence. >> Read More

The facts are clear, twelve world-recognized Kratom experts that have come together to conclude Kratom is in fact safe. The proof is in a 25 page paper by Dr. Jack E. Henningfield. >> Read More

As you know, the Ohio Board of Pharmacy is considering recommending a ban on kratom. We have a short window to send our clear, science-based message to the members of this Board. >> Read More

Because of your outreach over the last few days, the Senate has stood firm and decided that SITSA WILL NOT be added to the other opioid legislation. >> Read More

It has come to our attention that Congressman Goodlatte and Senator Grassley are trying to force the Senate to vote on passing SITSA without a Senate Hearing. There is no conference committee, so their pathway to get this done is pretty clear. >> Read More

The American Kratom Association submitted an eleven-page letter and a petition signed by more than 40,000 Americans asking the U.S. Drug Enforcement Administration (DEA) to keep the current regulatory structure in place for kratom, a natural botanical in the coffee family native to Southeast Asia. >> Read More

The fight to keep kratom legal is getting more and more intense and once again, we need your help to send a loud message to the folks at the DEA and on Capitol Hill. >> Learn more and sign the petition

You cannot pick up a newspaper or hear a news report out of Washington, DC that does not expose the bias held by rogue individuals within our government… >> Read More

Request comes after NIDA and the FDA remove information related to the safety of kratom from NIDA’s official website. Click here to read letter from NIDA director >>

Mac Haddow, the Senior Fellow of Public Policy at the American Kratom Association has published a legislative report that offers an updated look on the fight against the SITSA Bill.

Nine leading scientists delivered a letter to U.S. Senate and House Leadership condemning the FDA recommendation for scheduling of the natural plant as a Schedule I banned substance, and urging the DEA… >>read more.

Partners Martin J. Hahn and Lynn W. Mehler issued the letter on April 23, 2018, condemning the FDA’s efforts to push a mandatory recall on all kratom products in light of the current salmonella outbreak among some kratom-related products.

We ask for your immediate action to protect the freedom of consumers to make their own health care decisions, and stop the FDA from their broad regulatory overreach.

On the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse.

“This letter sends a loud and clear message to the DEA that they need to look at the actual science of kratom, not the misinformation being pushed by the FDA” >> Learn More

Use this easy form to contact your representatives in Congress. Let them know you support kratom’s legality and urge them to sign two Dear Colleague Letters circulating in the House: the Polis/Brat letter to the FDA and the Pocan/LoBiondo letter to the DEA.

The AKA delivered its’ open letter to the DEA asking them to fulfill mandates to conduct thorough and independent analysis on kratom.

Denver Environmental Health recently banned the sale of kratom for human consumption following a public-health advisory warning.

THE UTAH STATE SENATE BUSINESS AND LABOR COMMITTEE FAVORABLY REPORTS SB 58, THE KRATOM CONSUMER PROTECTION ACT, ON A STRONG 5-1 BIPARTISAN VOTE AND ADVANCES THE BILL TO THE FULL SENATE >> LEARN MORE

SCOTT GOTTLIEB WANTS TO CREATE A DE-FACTO NATIONAL SHADOW BAN ON KRATOM. >> LEARN MORE

On October 19, 2018, we are asking that kratom supporters around the United States participate in the Save Kratom Legislative Day and visit the local office of their U.S. Congressman/Congresswoman to deliver an information packet on kratom (the AKA will provide a link to download) and to let them know that we need their help to keep kratom legal. >> LEARN MORE

Stand up to Trump: tell him to stop promoting dangerous drug war tactics and to start prioritizing sensible drug policies. >> ACT NOW

Kratom Warriors: We’re sounding the alarm. If Scott Gottlieb continues to spew his lies about kratom, the DEA will schedule it. >> JOIN THE FIGHT NOW AND DONATE

WASHINGTON, D.C., August 20, 2018 – The American Kratom Association (AKA) published its “Good Manufacturing Practice (GMP) Standards for the Manufacture of Kratom Products” to provide specific guidance to kratom manufacturers and vendors in the manufacturing and marketing of kratom products… >> Read more

WASHINGTON, DC – August 14, 2018 – Peer-reviewed documentation concerning 44 deaths that the Food and Drug Administration (FDA) has cited to persuade the Drug Enforcement Administration (DEA) to place natural kratom… >> Read more

In a recent update of its official position on the botanical kratom, the National Institute of Drug Abuse (NIDA) affirmed that, “Kratom by itself is not associated with fatal overdose,” explaining that only when the natural ingredient is contaminated or “laced with other compounds” has it been associated with deaths.

The U.S. House of Representatives passed H.R. 6 on Friday that combined 58 different bills that attempt to end the scourge of the opioid epidemic in America.

Kratom is under attack from the SITSA bill. The FDA has lobbied the Speaker of the House and they are trying to force the SITSA Bill to the House Floor without the amendment to protect Kratom from a back-door scheduling maneuver. CLICK TO CONTACT YOUR CONGRESSMAN

Once again, a united effort in educating representatives results in kratom remaining legal.

The Salmonella outbreak in some kratom products has dominated the news cycle across the country over the past three weeks, largely because of the war on kratom that the FDA is waging in their broader effort to criminalize kratom manufacturers and consumers.

Since you’ve invested in us, we are investing in you. Here are some kratom updates you should know and BEA projects we’ve been working on.

The American Kratom Association’s Response
from Dave Herman, Board Chairman

Do you consider yourself an upstanding citizen? Will you take action when the time is right? Do you care about your nation’s well-being? Your own well-being.

In response to the latest FDA comment cautioning against the dangers of kratom, we kindly issue our response.

The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom.

It is time to have your voice count and be heard at a time when it matters the most.

This is a great resource that highlights the current scientific and legal controversies regarding kratom.

A Letter From AKA Chairman Dave Herman: Our Fight Against Last Week’s FDA Warning & What It Means to the Kratom Community